USP30 and acute myeloid leukemia: Survival analysis showed that high expression of USP30-AS1 was associated with a lower overall survival rate (***p < 0.001, Fig. 1B), indicating that the high expression of USP30-AS1 was associated with the poor prognosis of AML.